Cargando…
A combination of genetically engineered oncolytic virus and melittin-CpG for cancer viro-chemo-immunotherapy
BACKGROUND: Immunotherapy has emerged as an efficient therapeutic approach for cancer management. However, stimulation of host immune system against cancer cells often fails to achieve promising clinical outcomes mainly owing to the immunosuppressive characteristics of the tumor microenvironment (TM...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210435/ https://www.ncbi.nlm.nih.gov/pubmed/37226233 http://dx.doi.org/10.1186/s12916-023-02901-y |